| 1 |
32069386 | Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis. | 2020 Apr |
2 |
| 2 |
32454480 | Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy. | 2020 |
4 |
| 3 |
32868378 | Cardiac changes in pediatric cancer survivors. | 2020 Dec |
1 |
| 4 |
31612011 | BNP as a marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer. | 2019 Nov |
6 |
| 5 |
29720563 | Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline Chemotherapy. | 2018 Jul |
1 |
| 6 |
30275150 | The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines. | 2018 Dec |
3 |
| 7 |
33817127 | Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity. | 2018 Jan |
2 |
| 8 |
31773007 | Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma. | 2017 Fall |
2 |
| 9 |
27079675 | The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. | 2016 Jun |
2 |
| 10 |
27123140 | Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity. | 2016 May |
5 |
| 11 |
22911020 | Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia. | 2013 Oct |
1 |
| 12 |
23018571 | Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer. | 2012 Nov |
1 |
| 13 |
19945181 | Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. | 2011 Apr 14 |
1 |
| 14 |
19430339 | The use of B-type natriuretic peptide in paediatric patients: a review of literature. | 2009 Apr |
1 |
| 15 |
18850478 | The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature. | 2008 Sep |
2 |
| 16 |
19688118 | Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity. | 2008 Sep |
3 |
| 17 |
17171687 | B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. | 2007 Nov |
2 |
| 18 |
17391467 | Early prediction of anthracycline induced cardiotoxicity. | 2007 Apr |
2 |
| 19 |
15875778 | Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. | 2005 May-Jun |
2 |
| 20 |
11279304 | Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. | 2000 |
2 |
| 21 |
9704703 | Elevated B-type natriuretic peptide levels after anthracycline administration. | 1998 Aug |
5 |